Literature DB >> 7901957

Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.

C O Zachariae1.   

Abstract

This thesis discusses the phenotypic characteristics of different inflammatory dermatological diseases and sets this into context with the specific chemotactic ability of different cytokines. It further discusses the biological properties of different chemotactic cytokines and their relevance in certain inflammatory diseases. The term chemotaxis was introduced in 1884 by Pfeffer, who described it as directional migration of leukocytes along a gradient. Regular studies of chemotaxis were, however, not possible until 1962 when Boyden developed the chemotaxis chamber technique. This test has since then been improved, and it is now possible to define and characterize chemoattractants and examine the special chemotactic behavior of leukocytes. We investigated T lymphocyte responses towards different chemoattractants using a modified Boyden chamber technique and found that approximately 50% of normal individuals have cells which respond whereas T-cells from the remaining persons did not respond. We therefore chose human T lymphocytic cell lines as target cells for chemotaxis screening to avoid inter-individual variations among donors. T lymphocytic infiltrates dominated by CD4+, CD45R0+ memory T cells are characteristic for many dermatological inflammatory diseases. We have therefore performed experiments to evaluate whether an earlier described epidermal lymphocyte chemotactic factor (ELCF) from skin overlying a tuberculin skin reaction in addition with other cytokines specifically attracts different subsets of lymphocytes. ELCF which probably reflects a mixture of different epidermal T lymphocyte chemotactic factors rather than a single factor was shown to specifically attract CD4+, CD45R0+ T lymphocytes in contrast to fMLP, IL-8, C5a and LTB4, which induced equal chemotaxis for both CD4+ and CD8+ T lymphocytes. A newly described inhibitory cytokine IL-10 selectively attracted the CD8+ subpopulation of T lymphocytes, and it is suggested that IL-10 could be an important factor in the downregulation of an inflammatory response. The recently discovered neutrophil chemotactic and activating factor IL-8 has been shown to be chemotactic for T lymphocytes as well. It belongs to a family of 8,000-10,000 KDa peptides of which a monocyte chemotactic and activating factor MCAF is also a member. We showed that mRNA for IL-8 could be expressed in highly purified T lymphocytes only upon stimulation with ionomycin and PHA or PMA and PHA, and to a lesser extent PMA and IL-2. This is consistent with other reports of T lymphocytes requiring two signals for cytokine production. We showed that it was only the CD4+ subpopulation of the T lymphocytes that expressed IL-8 mRNA.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901957

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  12 in total

1.  Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors:  S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection.

Authors:  Erik P Lillehoj; Wei Guang; Sang W Hyun; Anguo Liu; Nicolas Hegerle; Raphael Simon; Alan S Cross; Hideharu Ishida; Irina G Luzina; Sergei P Atamas; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

3.  Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation.

Authors:  Gregory M Cooper; Eric D Miller; Gary E Decesare; Arvydas Usas; Emily L Lensie; Michael R Bykowski; Johnny Huard; Lee E Weiss; Joseph E Losee; Phil G Campbell
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

4.  The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury.

Authors:  Mitsuhiro Yamada; Hiroshi Kubo; Seiichi Kobayashi; Kota Ishizawa; Mei He; Takaya Suzuki; Naoya Fujino; Hiroyuki Kunishima; Masamitsu Hatta; Katsushi Nishimaki; Tetsuji Aoyagi; Kouichi Tokuda; Miho Kitagawa; Hisakazu Yano; Hirokazu Tamamura; Nobutaka Fujii; Mitsuo Kaku
Journal:  Cell Mol Immunol       Date:  2011-04-04       Impact factor: 11.530

Review 5.  The blood-brain barrier, chemokines and multiple sclerosis.

Authors:  David W Holman; Robyn S Klein; Richard M Ransohoff
Journal:  Biochim Biophys Acta       Date:  2010-08-06

6.  Expression kinetics of human periodontal ligament fibroblasts in the early phases of orthodontic tooth movement.

Authors:  Agnes Schröder; Kathrin Bauer; Gerrit Spanier; Peter Proff; Michael Wolf; Christian Kirschneck
Journal:  J Orofac Orthop       Date:  2018-07-17       Impact factor: 1.938

Review 7.  Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers.

Authors:  Jessica L Williams; David W Holman; Robyn S Klein
Journal:  Front Cell Neurosci       Date:  2014-05-28       Impact factor: 5.505

8.  Human Mig chemokine: biochemical and functional characterization.

Authors:  F Liao; R L Rabin; J R Yannelli; L G Koniaris; P Vanguri; J M Farber
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  A comparison of neutral and immune genetic variation in Atlantic salmon, Salmo salar L. in Chilean aquaculture facilities.

Authors:  David S Portnoy; Christopher M Hollenbeck; R Rodrigo Vidal; John R Gold
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria.

Authors:  Alexander Pretsch; Michael Nagl; Katja Schwendinger; Birgit Kreiseder; Martina Wiederstein; Dagmar Pretsch; Miroslav Genov; Ralph Hollaus; Daniela Zinssmeister; Abdesamad Debbab; Harald Hundsberger; Andreas Eger; Peter Proksch; Christoph Wiesner
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.